Quantcast

Latest Diabetes mellitus type 1 Stories

2014-10-31 08:26:32

Conference Call Scheduled for Monday, November 3, 2014 at 10:00 a.m. Eastern time JERUSALEM, October 31, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP)(http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announces that the company will host a conference call to discuss the clinical results from its Phase IIa clinical trial of ORMD-0801, the company's proprietary oral insulin capsules, to...

2014-10-30 16:26:09

ALEXANDRIA, Va., Oct. 30, 2014 /PRNewswire-USNewswire/ -- The holidays are a time to enjoy good food and time-honored traditions. With family and friends gathered 'round, you want to serve a meal to remember. The November 2014 issue of Diabetes Forecast®, the Healthy Living Magazine of the American Diabetes Association, offers 12 healthy, festive recipes inspired by favorite traditions from around the United States. In Holiday Celebrations from Coast to Coast, readers will be drawn to the...

2014-10-29 08:34:57

First Ever Person with Type 1 Diabetes Receives Experimental Encapsulated Human Stem Cell-Derived Beta Cell Replacement Therapy NEW YORK, Oct. 29, 2014 /PRNewswire-USNewswire/ -- JDRF, the leading research and advocacy organization funding type 1 diabetes (T1D) research, announced today that JDRF-funded partner, ViaCyte, Inc., a leading regenerative medicine company, has for the first time ever implanted a person with type 1 diabetes (T1D) with an experimental encapsulated cell...

2014-10-29 08:34:38

SAN DIEGO, Oct. 29, 2014 /PRNewswire/ -- ViaCyte, Inc., a privately-held regenerative medicine company, announced today that the first patient in its Phase 1/2 study was successfully implanted with VC-01(TM), its embryonic stem cell-derived islet replacement product candidate being developed as a treatment for type 1 diabetes. This Phase 1/2 clinical trial, designed to evaluate the VC-01 product candidate directly in patients with type 1 diabetes, is initially being conducted at UC...

2014-10-23 20:29:36

PASADENA, Calif., Oct. 23, 2014 /PRNewswire/ -- The rate of non-Hispanic white youth diagnosed with type 1 diabetes increased significantly from 2002 to 2009 in all but the youngest age group of children, according to a new study published today in the journal Diabetes. http://photos.prnewswire.com/prnvar/20130718/SF49717LOGO The study included data from more than 2 million children and adolescents living in diverse geographic regions of the United States. Within this population,...

2014-10-22 08:32:22

Demonstrates Proof-of-Concept for ORMD-0801 Oral Insulin to Reduce Exogenous Insulin Requirements JERUSALEM, October 22, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com ), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today reported positive top-line clinical results from its Phase IIa clinical trial of ORMD-0801, the company's proprietary oral insulin capsules, to treat type 1...

2014-10-21 08:33:10

Uppsala University Hospital in Sweden will enroll 8 patients in the study, partially supported by a recent grant by the JDRF ROSH HAAYIN, Israel, October 21, 2014 /PRNewswire/ -- Beta-O2 announced today that the first patient participating in the company's first broad study of the ssAir Bio-Artificial Pancreas has been successfully implanted. ssAir is in development as a treatment and a potential cure for type 1 diabetes (T1D). Approximately 3 million people have T1D in the...

2014-10-21 08:29:17

NEW YORK, Oct. 21, 2014 /PRNewswire/ -- Lazar Partners, a strategic communications firm for companies in the biopharma and medical device space, today announced the firm has been named the recipient of two PR Agency Elite awards by PR News for their work with partner Insulet Corporation on the diabetes blog, Suite D. Lazar Partners was nominated as a finalist and received honorable mention awards in both the Advocacy and Content Marketing categories. Winners were announced at PR...

The doctor takes from the child blood.
2014-10-20 02:30:06

Provided by Dr. Tsai Chung-Li, Diabetologia A new study published in Diabetologia (the journal of the European Association for the Study of Diabetes) shows that children who have been infected with enterovirus are 48% more likely to have developed type 1 diabetes. The study is by Dr. Tsai Chung-Li, China Medical University, Taiwan, and colleagues. "Type 1 diabetes is considered to be caused by complex interaction between genetic susceptibility, the immune system, and environmental...

2014-10-15 23:06:04

AAHOA's donation will boost efforts to research and end type 1 diabetes Atlanta, GA (PRWEB) October 15, 2014 The Asian American Hotel Owners Association (AAHOA), the voice of owners in the hospitality industry and a supporter of healthy living, announced today that the organization will donate $5,000 to the Juvenile Diabetes Research Foundation (JDRF) during its Southeast Texas Regional Conference in Houston, Texas. “Southeast Texas is our largest region, and we felt it fitting to...


Latest Diabetes mellitus type 1 Reference Libraries

Diabetes (journal)
2012-05-12 21:44:48

Diabetes is a peer-reviewed medical journal published since 1952 by the American Diabetes Association. Diabetes is a separate journal from the journal Diabetes Care, which is also published by the ADA. Diabetes covers research about the physiology and pathophysiology of diabetes mellitus, including any aspect of laboratory, animal or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic...

More Articles (1 articles) »
Word of the Day
maffling
  • To stammer.
  • Present participle of maffle, to stammer.
  • A simpleton.
The word 'maffle' may come from a Dutch word meaning 'to move the jaws' or a French word meaning 'having large cheeks'.